Life and Health
Life and Health Technology
52. We are actively advancing the integrated development of life and health technology at upstream, midstream and downstream levels. On upstream R&D, we will pursue its development through a "One plus Three" model, involving the headquarters of the Life and Health Technology Research Institutes to be set up in the Hong Kong Park of the Hetao Co-operation Zone (Hetao Hong Kong Park) and the three branches to be established by universities. In addition, we have established various R&D centres under the InnoHK Research Clusters. On midstream outcome transformation, the Research, Academic and Industry Sectors One‑plus (RAISe+) Scheme has supported 15 projects. As for downstream industries, three major I&T parks together host nearly 500 relevant enterprises and organisations, creating a vibrant ecosystem.
International Health and Medical Innovation Hub
R&D and Transformation of Biomedicine Technology
53. The Greater Bay Area International Clinical Trial Institute situated in the Hetao Hong Kong Park has launched a collaboration platform with the Shenzhen Park. It provides a one‑stop clinical trial support platform that brings together researchers and integrates databases for promoting R&D of biomedicine and vaccines.
54. The International Clinical Trial Academy will be established next year, which will help enable the Mainland's biomedicine technology to go global and attract foreign investments, thereby helping Hong Kong to develop into an international health and medical innovation hub.
Cross‑boundary Medical Collaboration
55. The Government established the Real‑World Study and Application Centre at the end of last year to support pharmaceutical companies and expedite the launch of innovative drugs and medical devices on the Mainland and international markets, contributing to the Mainland's drug regulatory science system.
Development of Chinese Medicine
56. The Chinese Medicine Development Blueprint outlines the vision for Chinese medicine development in Hong Kong, with the aim of promoting comprehensive, high‑quality and high‑standard development of Chinese medicine. We will inject $500 million into the Chinese Medicine Development Fund for undertaking research, training and international publicity on strategic themes.
57. The Chinese Medicine Hospital of Hong Kong and the Government Chinese Medicines Testing Institute have commenced services. The new facilities will help spur the development of Chinese medicine services, scientific research and innovation and standard‑setting, for showcasing the edge of Chinese medicine to the world.
| Previous Page | Content | Next Page |
